AIIMS Delhi has resumed free Therapeutic Drug Monitoring (TDM) tests for epilepsy patients. This initiative reduces financial ...

Bright Minds Biosciences has debuted glowing phase 2 results for its lead anti-seizure asset, giving the biotech’s stock a ...

Shares of Bright Minds Biosciences rose after the company released positive topline results from its phase two trial of a treatment for patients with drug-resistant Absence Seizures and Developmental ...

The All India Institute of Medical Sciences has introduced a free therapeutic drug monitoring test for patients with epilepsy ...

BMB-101 demonstrated significant anti-seizure benefit in both cohorts with favorable safety and tolerability Absence: 73.1% ...

A long-running debate over Tamiflu’s safety in children may finally be settled. Researchers found that influenza, not the ...

Ceribell’s LVO Stroke is underpinned by the same EEG monitoring technology used in its seizure and delirium monitoring ...

In findings that raise a variety of questions about how our brains work, and even about the nature of consciousness, UC Santa ...

Paris Regional Health announced that Spriha Pavuluri, MD, has joined its medical staff and is now offering comprehensive ...

After decades of advocacy, research, and state-level experimentation, cannabis has finally been rescheduled from Schedule I ...

At King Faisal Specialist Hospital & Research Centre (KFSHRC), the treatment of drug-resistant epilepsy has developed over decades into a comprehensive clinical program that combines advanced ...

From AI-powered drug discovery to regenerative therapies and next-generation neurology tools, Mayo Clinic researchers made significant strides in 2025 toward predicting, preventing and treating some o ...